Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Hunt for the origin of allergy - comparing the Finnish and Russian Karelia.

Haahtela T, Laatikainen T, Alenius H, Auvinen P, Fyhrquist N, Hanski I, von Hertzen L, Jousilahti P, Kosunen TU, Markelova O, Mäkelä MJ, Pantelejev V, Uhanov M, Zilber E, Vartiainen E.

Clin Exp Allergy. 2015 May;45(5):891-901. doi: 10.1111/cea.12527.

PMID:
25772429
2.

Acinetobacter species in the skin microbiota protect against allergic sensitization and inflammation.

Fyhrquist N, Ruokolainen L, Suomalainen A, Lehtimäki S, Veckman V, Vendelin J, Karisola P, Lehto M, Savinko T, Jarva H, Kosunen TU, Corander J, Auvinen P, Paulin L, von Hertzen L, Laatikainen T, Mäkelä M, Haahtela T, Greco D, Hanski I, Alenius H.

J Allergy Clin Immunol. 2014 Dec;134(6):1301-1309.e11. doi: 10.1016/j.jaci.2014.07.059. Epub 2014 Sep 26.

PMID:
25262465
3.

Environmental biodiversity, human microbiota, and allergy are interrelated.

Hanski I, von Hertzen L, Fyhrquist N, Koskinen K, Torppa K, Laatikainen T, Karisola P, Auvinen P, Paulin L, Mäkelä MJ, Vartiainen E, Kosunen TU, Alenius H, Haahtela T.

Proc Natl Acad Sci U S A. 2012 May 22;109(21):8334-9. doi: 10.1073/pnas.1205624109. Epub 2012 May 7.

4.

Allergy gap between Finnish and Russian Karelia on increase.

Laatikainen T, von Hertzen L, Koskinen JP, Mäkelä MJ, Jousilahti P, Kosunen TU, Vlasoff T, Ahlström M, Vartiainen E, Haahtela T.

Allergy. 2011 Jul;66(7):886-92. doi: 10.1111/j.1398-9995.2010.02533.x. Epub 2011 Jan 21.

PMID:
21255037
5.

Longitudinal analysis of serological responses of adults to Helicobacter pylori antigens.

Perez-Perez GI, Maw AM, Feingold-Link L, Gunn J, Bowers AL, Minano C, Rautelin H, Kosunen TU, Blaser MJ.

J Infect Dis. 2010 Sep 15;202(6):916-23. doi: 10.1086/655660.

6.

Gastric cancers in Finnish patients after cure of Helicobacter pylori infection: A cohort study.

Kosunen TU, Pukkala E, Sarna S, Seppälä K, Aromaa A, Knekt P, Rautelin H.

Int J Cancer. 2011 Jan 15;128(2):433-9. doi: 10.1002/ijc.25337. Epub 2010 Mar 22.

7.

A "screen-and-treat" approach for Helicobacter pylori infection: a population-based study in Vammala, Finland.

Salomaa-Räsänen A, Kosunen TU, Aromaa AR, Knekt P, Sarna S, Rautelin H.

Helicobacter. 2010 Feb;15(1):28-37. doi: 10.1111/j.1523-5378.2009.00727.x.

PMID:
20302587
8.

Cure of Helicobacter pylori infection in all compliant patients: report on 644 subjects.

Seppälä K, Kosunen TU, Veijola L, Sipponen P, Arkkila PE, Rautelin H, Tilvis R.

Scand J Gastroenterol. 2008;43(9):1149-50. doi: 10.1080/00365520802078366. No abstract available.

PMID:
18609180
9.

A disparity in the association of asthma, rhinitis, and eczema with allergen-specific IgE between Finnish and Russian Karelia.

Pekkarinen PT, von Hertzen L, Laatikainen T, Mäkelä MJ, Jousilahti P, Kosunen TU, Pantelejev V, Vartiainen E, Haahtela T.

Allergy. 2007 Mar;62(3):281-7.

PMID:
17298345
10.

Change in the pattern of IgE reactivity to timothy grass and birch pollen allergens over a 20-year period.

Movérare R, Kosunen TU, Haahtela T.

J Investig Allergol Clin Immunol. 2006;16(5):274-8.

11.

Clinical significance of widespread gastric metaplasia in the duodenal bulb.

Veijola L, Sankila A, Rautelin H, Kosunen TU, Sipponen P, Hyvärinen H, Tilvis R, Sarna S, Arkkila PE, Seppälä K.

J Clin Gastroenterol. 2006 Jul;40(6):510-4.

PMID:
16825933
12.

Helicobacter pylori-induced indoleamine 2,3-dioxygenase activity in vivo is regulated by TGFB1 and CTLA4 polymorphisms.

Raitala A, Karjalainen J, Oja SS, Kosunen TU, Hurme M.

Mol Immunol. 2007 Feb;44(5):1011-4. Epub 2006 Apr 18.

PMID:
16620985
13.

Infectious burden as a determinant of atopy-- a comparison between adults in Finnish and Russian Karelia.

von Hertzen LC, Laatikainen T, Mäkelä MJ, Jousilahti P, Kosunen TU, Petays T, Pussinen PJ, Haahtela T, Vartiainen E.

Int Arch Allergy Immunol. 2006;140(2):89-95. Epub 2006 Mar 22.

PMID:
16554659
14.
15.

IgA antibodies in persisting Helicobacter pylori infection in Finnish adults.

Salomaa-Räsänen A, Kosunen TU, Karjalainen J, Aromaa A, Knekt P, Sarna S, Rautelin H.

Clin Microbiol Infect. 2006 Mar;12(3):236-40.

16.

Association of Helicobacter pylori IgA antibodies with the risk of peptic ulcer disease and gastric cancer.

Kosunen TU, Seppala K, Sarna S, Aromaa A, Knekt P, Virtamo J, Salomaa-Rasanen A, Rautelin H.

World J Gastroenterol. 2005 Nov 21;11(43):6871-4.

17.

Growing disparities in atopy between the Finns and the Russians: a comparison of 2 generations.

von Hertzen L, Mäkelä MJ, Petäys T, Jousilahti P, Kosunen TU, Laatikainen T, Vartiainen E, Haahtela T.

J Allergy Clin Immunol. 2006 Jan;117(1):151-7. Epub 2005 Oct 3.

PMID:
16387599
18.

Normal serum pepsinogen I levels in adults: a population-based study with special reference to Helicobacter pylori infection and parietal cell antibodies.

Hokkanen S, Kosunen TU, Sarna S, Miettinen A, Salomaa A, Aromaa A, Knekt P, Rautelin HI.

Scand J Clin Lab Invest. 2005;65(4):291-9.

PMID:
16076684
19.

Indoleamine 2,3-dioxygenase (IDO) activity is lower in atopic than in non-atopic individuals and is enhanced by environmental factors protecting from atopy.

Raitala A, Karjalainen J, Oja SS, Kosunen TU, Hurme M.

Mol Immunol. 2006 Mar;43(7):1054-6. Epub 2005 Jun 29.

PMID:
15992929
20.

Genetic and environmental factors in the immunopathogenesis of atopy: interaction of Helicobacter pylori infection and IL4 genetics.

Pessi T, Virta M, Adjers K, Karjalainen J, Rautelin H, Kosunen TU, Hurme M.

Int Arch Allergy Immunol. 2005 Aug;137(4):282-8. Epub 2005 Jun 17.

PMID:
15970635
21.

Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers.

Arkkila PE, Seppälä K, Kosunen TU, Sipponen P, Mäkinen J, Rautelin H, Färkkilä M.

Eur J Gastroenterol Hepatol. 2005 Jan;17(1):93-101.

PMID:
15647648
22.

Age-dependent accuracy of Helicobacter pylori antibody assays for adults, with special emphasis on atrophic gastritis.

Salomaa-Räsänen A, Kosunen TU, Mattila J, Sarna S, Rautelin H.

Clin Diagn Lab Immunol. 2004 Nov;11(6):1185-8.

23.

Cost-benefit analysis of Helicobacter pylori screening.

Leivo T, Salomaa A, Kosunen TU, Tuominen R, Färkkilä M, Linna M, Sintonen H.

Health Policy. 2004 Oct;70(1):85-96.

PMID:
15312711
24.

Helicobacter pylori infection in Finland.

Rautelin H, Kosunen TU.

Ann Med. 2004;36(2):82-8. Review.

PMID:
15119828
25.
26.

Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer.

Arkkila PE, Seppälä K, Kosunen TU, Haapiainen R, Kivilaakso E, Sipponen P, Mäkinen J, Nuutinen H, Rautelin H, Färkkilä MA.

Am J Gastroenterol. 2003 Oct;98(10):2149-56.

PMID:
14572560
27.

Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis.

Kokkola A, Kosunen TU, Puolakkainen P, Sipponen P, Harkonen M, Laxen F, Virtamo J, Haapiainen R, Rautelin H.

APMIS. 2003 Jun;111(6):619-24.

PMID:
12969017
28.

Prevention and suppression of Helicobacter felis infection in mice using colostral preparation with specific antibodies.

Marnila P, Rokka S, Rehnberg-Laiho L, Kärkkäinen P, Kosunen TU, Rautelin H, Hänninen ML, Syväoja EL, Korhonen H.

Helicobacter. 2003 Jun;8(3):192-201.

PMID:
12752731
29.

Increase of allergen-specific immunoglobulin E antibodies from 1973 to 1994 in a Finnish population and a possible relationship to Helicobacter pylori infections.

Kosunen TU, Höök-Nikanne J, Salomaa A, Sarna S, Aromaa A, Haahtela T.

Clin Exp Allergy. 2002 Mar;32(3):373-8.

PMID:
11940066
30.

The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia.

Kokkola A, Sipponen P, Rautelin H, Härkönen M, Kosunen TU, Haapiainen R, Puolakkainen P.

Aliment Pharmacol Ther. 2002 Mar;16(3):515-20.

31.

Evidence that cagA(+) Helicobacter pylori strains are disappearing more rapidly than cagA(-) strains.

Perez-Perez GI, Salomaa A, Kosunen TU, Daverman B, Rautelin H, Aromaa A, Knekt P, Blaser MJ.

Gut. 2002 Mar;50(3):295-8.

32.

Decreasing prevalence of helicobacter antibodies in Finland, with reference to the decreasing incidence of gastric cancer.

Rehnberg-Laiho L, Rautelin H, Koskela P, Sarna S, Pukkala E, Aromaa A, Knekt P, Kosunen TU.

Epidemiol Infect. 2001 Feb;126(1):37-42.

33.
34.

Is Helicobacter pylori infection associated with chronic urticaria?

Hook-Nikanne J, Varjonen E, Harvima RJ, Kosunen TU.

Acta Derm Venereol. 2000 Nov-Dec;80(6):425-6.

35.

Association of CagA-positive infection with Helicobacter pylori antibodies of IgA class.

Rautelin HI, Oksanen AM, Karttunen RA, Seppälä KM, Virtamo JR, Aromaa AJ, Kosunen TU.

Ann Med. 2000 Dec;32(9):652-6.

PMID:
11209973
36.

Cure of Helicobacter pylori infection after failed primary treatment: one-center results from 120 patients.

Seppälä K, Kosunen TU, Nuutinen H, Sipponen P, Rautelin H, Sarna S, Hyvärinen H, Färkkilä M, Miettinen TA.

Scand J Gastroenterol. 2000 Sep;35(9):929-34.

PMID:
11063151
37.

Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: comparison of histology, 13C-urea breath test, and serology.

Kokkola A, Rautelin H, Puolakkainen P, Sipponen P, Färkkilä M, Haapiainen R, Kosunen TU.

Scand J Gastroenterol. 2000 Feb;35(2):138-41.

PMID:
10720110
38.

Helicobacter antibodies in Finnish centenarians.

Rehnberg-Laiho L, Louhija J, Rautelin H, Jusufovic J, Tilvis R, Miettinen A, Kosunen TU.

J Gerontol A Biol Sci Med Sci. 1999 Aug;54(8):M400-3.

PMID:
10496545
39.

Persisting Helicobacter antibodies in Finnish children and adolescents between two and twenty years of age.

Rehnberg-Laiho L, Rautelin H, Valle M, Kosunen TU.

Pediatr Infect Dis J. 1998 Sep;17(9):796-9.

PMID:
9779764
40.

Positive result by serology indicates active Helicobacter pylori infection in patients with atrophic gastritis.

Kokkola A, Rautelin H, Puolakkainen P, Sipponen P, Färkkilä M, Haapiainen R, Kosunen TU.

J Clin Microbiol. 1998 Jun;36(6):1808-10.

41.

Flavodoxin-dependent pyruvate oxidation, acetate production and metronidazole reduction by Helicobacter pylori.

Kaihovaara P, Höök-Nikanne J, Uusi-Oukari M, Kosunen TU, Salaspuro M.

J Antimicrob Chemother. 1998 Feb;41(2):171-7.

PMID:
9533458
42.

Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland.

Kosunen TU, Aromaa A, Knekt P, Salomaa A, Rautelin H, Lohi P, Heinonen OP.

Epidemiol Infect. 1997 Aug;119(1):29-34.

43.

Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in a general elderly population.

Strandberg TE, Tilvis RS, Vuoristo M, Lindroos M, Kosunen TU.

BMJ. 1997 May 3;314(7090):1317-8. No abstract available.

44.

Culture of Helicobacter pylori from gastric biopsies transported in biopsy urease test tubes.

Rautelin H, Seppälä K, Nuutinen H, Kärkkäinen P, Sipponen P, Kosunen TU.

Eur J Clin Microbiol Infect Dis. 1997 May;16(5):380-3.

PMID:
9228479
45.

Serological findings in patients with acute syndromes fulfilling the proposed criteria of adult onset Still's disease.

Valtonen JM, Kosunen TU, Karjalainen J, Valtonen M, Leirisalo-Repo M, Valtonen VV.

Scand J Rheumatol. 1997;26(5):342-5.

PMID:
9385343
46.

Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer.

Aromaa A, Kosunen TU, Knekt P, Maatela J, Teppo L, Heinonen OP, Härkönen M, Hakama MK.

Am J Epidemiol. 1996 Jul 15;144(2):142-9.

PMID:
8678045
47.

Gastric inflammation and neutrophil-activating and cytotoxin-producing Helicobacter pylori strains.

Rautelin H, Sipponen P, Seppälä K, Sarna S, Danielsson D, Kosunen TU.

Scand J Gastroenterol. 1996 Jul;31(7):639-42.

PMID:
8819210
48.

The Helicobacter felis mouse model in assessing anti-Helicobacter therapies and gastric mucosal prostaglandin E2 levels.

Höök-Nikanne J, Aho P, Kärkkäinen P, Kosunen TU, Salaspuro M.

Scand J Gastroenterol. 1996 Apr;31(4):334-8.

PMID:
8726299
49.

Rate of Helicobacter pylori acquisition among Finnish adults: a fifteen year follow-up.

Sipponen P, Kosunen TU, Samloff IM, Heinonen OP, Siurala M.

Scand J Gastroenterol. 1996 Mar;31(3):229-32.

PMID:
8833351
50.

High frequency of helicobacter negative gastritis in patients with Crohn's disease.

Halme L, Kärkkäinen P, Rautelin H, Kosunen TU, Sipponen P.

Gut. 1996 Mar;38(3):379-83.

Supplemental Content

Loading ...
Support Center